I would echo some of Dr. Meulien's comments. We believe very strongly in the potential of Canada. In large part, we in our industry are Canadians who are going out into our global networks and advocating and promoting to bring investments back to Canada. We advocate for Canada.
For us, there are a number of factors that we have to consider when we are building our business case to bring an investment to the country. Intellectual property is an important piece. I would agree that our system is okay; it's just not great, and it has remained relatively unchanged for the past 25 years.
Therefore, when you're looking at the climate, the key for our industry, as I said, is a stable and predictable business climate. You're looking at a variety of different factors. You're looking at the regulatory system. Is it stable? Is it predictable? You're looking at taxation policy. You're looking at the talent pool. You're looking at the links between teaching hospitals and academic institutions. Also, you are looking at the intellectual property system.
For us, it's about trying to understand where we want our system to go, and not 10 years ago, but where we want it to be in 10 years from now and in 25 years from now. Where do we want health research to be? We've heard a lot about its potential. I think the key is that we have this opportunity in our discussions with Europe to really be able to modernize and to make some strategic amendments that will help bring us into that future of health research.